Henlius Doses First Patient In China For Ophthalmic Bevacizumab

Follows US FDA Approving Henlius’ Investigational New Drug Application

 
• By Dean Rudge
Eye
Henlius has also developed bevacizumab for cancer • Source: Shutterstock

More from Biosimilars

More from Products